Trader consensus on Polymarket prices an 83% chance of no new WHO-designated COVID-19 variant of concern before 2027, driven by sustained low global case rates, declining hospitalizations, and effective population immunity from vaccines and prior infections. Despite buzz around the highly mutated Omicron descendant BA.3.2 ("Cicada"), detected in 29 U.S. states and 23+ countries since late March 2026, it remains under monitoring without evidence of heightened severity, dominance, or vaccine evasion warranting VOC status—test positivity hovers below 4%. Ongoing genomic surveillance and May 2026 WHO vaccine antigen deliberations underscore stability, with historical patterns showing Omicron subvariants rarely escalating to VOC amid robust defenses.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourOui
$231,738 Vol.
$231,738 Vol.
Oui
$231,738 Vol.
$231,738 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Marché ouvert : Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket prices an 83% chance of no new WHO-designated COVID-19 variant of concern before 2027, driven by sustained low global case rates, declining hospitalizations, and effective population immunity from vaccines and prior infections. Despite buzz around the highly mutated Omicron descendant BA.3.2 ("Cicada"), detected in 29 U.S. states and 23+ countries since late March 2026, it remains under monitoring without evidence of heightened severity, dominance, or vaccine evasion warranting VOC status—test positivity hovers below 4%. Ongoing genomic surveillance and May 2026 WHO vaccine antigen deliberations underscore stability, with historical patterns showing Omicron subvariants rarely escalating to VOC amid robust defenses.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes